NY State Senate Bill 2017-S264

Senate Bill S264

2017-2018 Legislative Session

Requires epinephrine auto-injector devices at children's overnight, summer day and traveling summer camps

download bill text pdf

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 03, 2018	referred to health
Jan 04, 2017	referred to health

2017-S264 (ACTIVE) - Details

See Assembly Version of this Bill:: A681
Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Amd §3000-c, add §1392-b, Pub Health L
Versions Introduced in Other Legislative Sessions:: 2009-2010: A9884
2011-2012: A1771
2013-2014: S5159, A262
2015-2016: S50, A606
2019-2020: S1480, A1050
2021-2022: S443, A552
2023-2024: S2555, A1828

2017-S264 (ACTIVE) - Summary

Requires epinephrine auto-injector devices at children's overnight, summer day and traveling summer day camps.

2017-S264 (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S264

 TITLE OF BILL :

An act to amend the public health law, in relation to requiring
epinephrine auto-injector devices at children's overnight, summer day
and traveling summer camps

 PURPOSE OR GENERAL IDEA OF BILL :

This bill will require children's overnight, summer day and traveling
summer camps to stock epinephrine auto-injector devices.

 SUMMARY OF SPECIFIC PROVISIONS :

Section one amends paragraph (a) of subdivision 1 of section 3000-c of
the public health law, as amended by chapter 350 of the laws of 2001
to delete references to children's summer day camps.

Section two amends the public health law by adding a new section
1392-b that defines "emergency health care provider." The section
requires that all entities operating children's summer camps must
maintain a collaborative agreement with an emergency health care
provide and keep epinephrine auto-injectors on the premises. This
section outlines the requirements for this collaborative agreement.
Regulations regarding possession and use of epinephrine auto-injector

devices are laid out. Use of such devices is considered first aid or
emergency treatment for the purpose of any statute relating to
liability.

Section three sets out the effective date.

 JUSTIFICATION :

Over the last 10 years, allergies have reached epidemic proportions.
More than 2 million Americans suffer from anaphylaxis.  The main
causes are insect stings or ingesting food or medication to which
someone is allergic. Children can face anaphylactic reactions
including hives, swellings, difficulty breathing, coma and death.
Unless they are given immediate attention for anaphylactic shock,
usually in the form of epinephrine, children can die.

Epinephrine auto-injectors are used to treat anaphylactic shock and
their availability in a given situation may be a matter of life and
death. They are commonly prescribed to and carried by persons with
severe allergies because they can be self-administered and are
fast-acting. Epinephrine is a form of adrenaline and is an effective
treatment for an anaphylactic reaction. It works rapidly, reducing the
swelling in the chest and airways to ease breathing. In most cases,
epinephrine fully prevents or reverses an anaphylactic reaction,
Governor Pataki signed the Epinephrine Auto-Injector Device Law in
1999. This law permits the possession and use of epinephrine
auto-injectors by non-certified and non-licensed personnel (including
specially trained staff in children's day, overnight, and traveling
camps), as well as health care providers certified at the level that
would normally allow for administration of medication. This law's
intent was to encourage greater acquisition and use of epinephrine
auto-injectors in order to reduce the number of deaths associated with
anaphylaxis.

However, children's summer camps currently have only the option of
carrying epinephrine auto-injectors. It is not required that they do
so. At the same time, children who participate in summer camp
activities are exposed to foods and outdoor situations that may be new
to them and that may potentially lead to life-threatening events (such
as bee stings or food allergies) and therefore to anaphylaxis.  This
bill would require summer camps to have epinephrine auto-injectors
available in the event of such an emergency.

 PRIOR LEGISLATIVE HISTORY :

S.50 of 2015-2016 (Hoylman): Died in Health
A.606 of 2015-2016 (Rosenthal): Died in Health
S.5159 of 2013-2014 (Hoylman): Died in Health
A.262 of 2013-2014 (Rosenthal): Died in Health

 FISCAL IMPLICATIONS :

None

 EFFECTIVE DATE :
This act shall take effect on the one hundred eightieth day after it
shall have become a law; provided that any rules and regulations
necessary to implement the provisions of this act on its effective
date are authorized and directed to be added, amended and/or repealed
on or before such date.

2017-S264 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    264
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                                (PREFILED)
 
                              January 4, 2017
                                ___________
 
 Introduced  by  Sen. HOYLMAN -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, in relation to requiring epineph-
   rine auto-injector devices at children's  overnight,  summer  day  and
   traveling summer camps

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Paragraph (a) of subdivision 1 of  section  3000-c  of  the
 public  health  law,  as  amended by chapter 373 of the laws of 2016, is
 amended to read as follows:
   (a) "Eligible person or entity" means  (i)  an  ambulance  service  or
 advanced  life support first response service; a certified first respon-
 der, emergency medical technician, or advanced emergency medical techni-
 cian, who is employed by or an enrolled member of any such  service;  OR
 (ii)  [a  children's  overnight  camp  as  defined in subdivision one of
 section thirteen hundred ninety-two of this chapter, a summer  day  camp
 as  defined in subdivision two of section thirteen hundred ninety-two of
 this chapter, a traveling summer day  camp  as  defined  in  subdivision
 three of section thirteen hundred ninety-two of this chapter or a person
 employed  by such a camp; (iii)] a school district, board of cooperative
 educational services, county vocational education and  extension  board,
 charter  school,  and non-public elementary and secondary school in this
 state or any person employed by any  such  entity;  or  [(iv)]  (III)  a
 sports,  entertainment,  amusement,  education,  government, day care or
 retail facility;  an  educational  institution,  youth  organization  or
 sports  league;  an establishment that serves food; or a person employed
 by such entity; [and] OR [(v)] (IV) any other person  or  entity  desig-
 nated  or  approved, or in a category designated or approved pursuant to
 regulations of the commissioner in consultation with  other  appropriate
 agencies.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets

                       [ ] is old law to be omitted.
                                                            LBD02055-01-7

 S. 264                              2
 
   §  2.  The public health law is amended by adding a new section 1392-b
 to read as follows:
   § 1392-B. EPINEPHRINE AUTO-INJECTOR DEVICES REQUIRED. 1.  DEFINITIONS.
 AS  USED  IN  THIS SECTION, "EMERGENCY HEALTH CARE PROVIDER" MEANS (A) A
 PHYSICIAN WITH KNOWLEDGE AND EXPERIENCE IN  THE  DELIVERY  OF  EMERGENCY
 CARE;  OR  (B)  A  HOSPITAL  LICENSED UNDER ARTICLE TWENTY-EIGHT OF THIS
 CHAPTER THAT PROVIDES EMERGENCY CARE.
   2. COLLABORATIVE AGREEMENT. (A) EVERY PERSON, FIRM, LIMITED  LIABILITY
 COMPANY,  ASSOCIATION  AND CORPORATION WHICH OPERATES A CHILDREN'S OVER-
 NIGHT, SUMMER DAY AND TRAVELING SUMMER DAY  CAMP,  AS  DEFINED  IN  THIS
 ARTICLE,  SHALL  MAINTAIN  A  COLLABORATIVE  AGREEMENT WITH AN EMERGENCY
 HEALTH CARE PROVIDER AND SHALL HAVE ON THE PREMISES AN EPINEPHRINE AUTO-
 INJECTOR DEVICE.
   (B) THE COLLABORATIVE AGREEMENT REQUIRED PURSUANT TO PARAGRAPH (A)  OF
 THIS  SUBDIVISION  SHALL  INCLUDE  A WRITTEN AGREEMENT THAT INCORPORATES
 WRITTEN PRACTICE PROTOCOLS,  AND  POLICIES  AND  PROCEDURES  THAT  SHALL
 ENSURE COMPLIANCE WITH THE PROVISIONS OF THIS SECTION. THE PERSON, FIRM,
 LIMITED  LIABILITY  COMPANY,  ORGANIZATION OR ENTITY OPERATING THE CHIL-
 DREN'S OVERNIGHT, SUMMER DAY AND TRAVELING SUMMER DAY CAMP SHALL FILE  A
 COPY  OF  THE  COLLABORATIVE  AGREEMENT WITH THE DEPARTMENT AND WITH THE
 APPROPRIATE REGIONAL COUNCIL PRIOR TO USING ANY EPINEPHRINE  AUTO-INJEC-
 TOR DEVICE.
   3. POSSESSION AND USE OF EPINEPHRINE AUTO-INJECTOR DEVICES. POSSESSION
 AND  USE  OF  EPINEPHRINE  AUTO-INJECTOR  DEVICES  SHALL  BE  LIMITED AS
 FOLLOWS:
   (A) NO PERSON SHALL USE AN  EPINEPHRINE  AUTO-INJECTOR  DEVICE  UNLESS
 SUCH  PERSON  SHALL HAVE SUCCESSFULLY COMPLETED A TRAINING COURSE IN THE
 USE OF EPINEPHRINE AUTO-INJECTOR DEVICES APPROVED  BY  THE  COMMISSIONER
 PURSUANT  TO THE RULES OF THE DEPARTMENT. THIS SECTION DOES NOT PROHIBIT
 THE USE OF AN EPINEPHRINE AUTO-INJECTOR DEVICE  (I)  BY  A  HEALTH  CARE
 PRACTITIONER  LICENSED  OR  CERTIFIED UNDER TITLE EIGHT OF THE EDUCATION
 LAW ACTING WITHIN THE SCOPE OF HIS OR HER PRACTICE, OR (II) BY A  PERSON
 ACTING PURSUANT TO A LAWFUL PRESCRIPTION.
   (B)  EVERY PERSON, FIRM, ORGANIZATION AND ENTITY AUTHORIZED TO POSSESS
 AND USE EPINEPHRINE AUTO-INJECTOR DEVICES PURSUANT TO THIS SECTION SHALL
 USE, MAINTAIN AND DISPOSE OF SUCH DEVICES PURSUANT TO REGULATIONS OF THE
 DEPARTMENT.
   (C) EVERY USE OF AN EPINEPHRINE AUTO-INJECTOR DEVICE PURSUANT TO  THIS
 SECTION  SHALL  IMMEDIATELY  BE  REPORTED  TO  THE EMERGENCY HEALTH CARE
 PROVIDER.
   4. APPLICATION OF OTHER LAWS. (A) USE OF AN EPINEPHRINE  AUTO-INJECTOR
 DEVICE  PURSUANT  TO THIS SECTION SHALL BE CONSIDERED FIRST AID OR EMER-
 GENCY TREATMENT FOR THE PURPOSE OF ANY STATUTE RELATING TO LIABILITY.
   (B) PURCHASE, ACQUISITION, POSSESSION OR USE OF AN  EPINEPHRINE  AUTO-
 INJECTOR DEVICE PURSUANT TO THIS SECTION SHALL NOT CONSTITUTE THE UNLAW-
 FUL PRACTICE OF A PROFESSION OR OTHER VIOLATION UNDER TITLE EIGHT OF THE
 EDUCATION LAW OR ARTICLE THIRTY-THREE OF THIS CHAPTER.
   (C)  ANY PERSON OTHERWISE AUTHORIZED TO SELL OR PROVIDE AN EPINEPHRINE
 AUTO-INJECTOR DEVICE MAY SELL OR PROVIDE IT TO A  PERSON  AUTHORIZED  TO
 POSSESS IT PURSUANT TO THIS SECTION.
   § 3. This act shall take effect on the one hundred eightieth day after
 it  shall  have become a law. Effective immediately, any rules and regu-
 lations necessary to implement the provisions of this act on its  effec-
 tive  date  are  authorized  and  directed  to  be added, amended and/or
 repealed on or before such date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.